The system can measure dozens of markers at the single-cell level and, one researcher said, could aid studies of cellular heterogeneity in diseases like cancer.
Waters experienced some sluggishness in the US market in the quarter, and the firm noted that its pharma business, in particular, had seen a shift toward Europe.
A review by Max Planck researcher Matthias Mann and colleagues suggests that improved mass spec performance could enable more effective plasma marker discovery.
The recent study highlights strengths and weaknesses of numerous platforms and may help end users choose the best assay for their circumstances.
The company will use the funds to refine a nanoparticle-based immunoenrichment approach to simplifying sample separations up front of mass spec analysis.
The group has identified proteins from nearly 90 percent of the predicted protein-coding genes, though the remaining 10 percent present significant challenges.
N-of-One will help Agena interpret cancer genomic data generated by its MassArray system as part of a recently launched reporting network.
According to one researcher, the instrument running an ion mobility-based workflow offers speed and sensitivity gains of up to 10-fold compared to other methods.
The agreement brings together Biognosys' Spectronaut Pulsar DIA software and Waters' SONAR data-independent acquisition mass spectrometry method.
Molecular Health will make its analysis tools available to aid in the interpretation of raw data generated by customers of Agena's MassArray system.
The scientists hope to incorporate the method, which can measure endogenous peptides at zeptomolar concentrations, in clinical trials starting next year.
An assay from a University of Victoria team demonstrates the suitability of MALDI mass spec for measuring low-abundance proteins in small clinical samples.
Areas like pharma and food and water testing could prove growth areas for the platform as instrument sales growth slows in the clinic microbiology space.
According to one of the researchers, the model could help streamline and improve mass spec workflows aimed at measuring proteins in extremely small samples.
Caprion will use its mass spec platform to measure Alzheimer's-linked proteins in the CSF of more than 200 patients and controls over three or more years.
A group of data independent-acquisition mass spec experts have developed guidelines and software to keep down false positive IDs in large-scale DIA datasets.
The partners aim to develop a diagnostic methodology for obtaining cancer cell molecular profiles to help guide immunotherapies.
The company reported revenues of $414.9 million as acquisitions boosted revenues 6 percent and foreign exchange rates lowered them by 2 percent.
Agena's cystic fibrosis panel includes more than 70 mutations in the CFTR gene that have been linked to the disease.
The new version of the mass spectrometry-based system adds 144 microbial species to its database and includes new tools for sample preparation.
The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.
A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.
Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.
In Science this week: analysis of DNA from ancient North Africans, and more.